---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-023699"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2026-04-03T23:59:59+00:00"
generated_at: "2026-05-15T07:35:38.256317+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience appoints John Sharp as CFO and reprices underwater options to $0.6150

## Summary
- John P. Sharp appointed CFO effective March 31, 2026; services via Lohman & Associates at $25,600/month for up to 64 hours.
- Board approved repricing of 2,420,978 outstanding options held by full-time employees to $0.6150/share (closing price on repricing date).
- Repriced options previously had exercise prices ranging from $1.055 to $14.56; include 1,103,959 options held by CEO Punit Dhillon and 396,295 held by COO Tuan Diep.
- Option repricing intended to retain and motivate eligible participants without additional dilution or cash compensation.
- Master Services Agreement with Lohman & Associates entered; Sharp will serve as principal financial and accounting officer.

## SEC filing metadata
- accession: 0001628280-26-023699
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2026-04-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000162828026023699/0001628280-26-023699-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000162828026023699/skye-20260331.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-023699
- JSON: https://secwatch.observer/filing/0001628280-26-023699.json
- Plain text: https://secwatch.observer/filing/0001628280-26-023699.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.